BioCentury | Jul 4, 2011
Company News

Par Pharmaceutical infectious, cancer, endocrine news

...will focus on the sale of Par's marketed drugs Megace ES megestrol acetate and Nascobal cyanocobalamin...
...anorexia, cachexia or any unexplained significant weight loss in AIDS patients. Nascobal is an intranasal cyanocobalamin...
...and $17.7 million for Nascobal in 2010. In 2009, Par acquired exclusive, worldwide rights to Nascobal...
BioCentury | Apr 6, 2009
Company News

Par Pharmaceutical, QOL Medical deal

...Par's Strativa Pharmaceuticals division acquired exclusive, worldwide rights to QOL's Nascobal cyanocobalamin nasal spray for $54.5...
...NASDAQ:MRNA, Bothell, Wash.) (formerly Nastech Pharmaceutical Co. Inc. ) in 2003. Strativa also acquired the Nascobal...
BioCentury | Jun 16, 2008
Strategy

Nastech slices and dices

...on its intranasal delivery technology. The company received FDA approval in 2005 for its Nascobal cyanocobalamin...
BioCentury | Jun 16, 2008
Strategy

MDRNA chronicles

...Schwarz Pharma, now part of UCB (Euronext:UCB), to exclusively market in the U.S. Nastech's Nascobal cyanocobalamin...
...ED. F. 6/17/03 - Questcor (NASDAQ:QCOR) says it will acquire Nastech's Nascobal nasal gel and Nascobal...
...nasal gel and Nascobal nasal spray for up to $18.2M.G. 2/1/05 - FDA approves Nastech's Nascobal...
BioCentury | Aug 13, 2007
Company News

Nastech, QOL Medical deal

...million milestone payment from QOL under a deal that granted QOL rights to NSTK's Nascobal cyanocobalamin...
...triggered by the issuance of a U.S. patent covering the nasal spray. NSTK originally sold Nascobal...
BioCentury | Aug 6, 2007
Clinical News

CaloMist cyanocobalamin regulatory update

...FDA approved an NDA from Fleming for CaloMist cyanocobalamin to maintain vitamin B-12 concentrations after normalization...
...CaloMist is an intranasal formulation of vitamin B-12. Fleming Pharmaceuticals , Fenton, Mo. Product: CaloMist cyanocobalamin...
BioCentury | Jan 8, 2007
Finance

Post-launch report

...Xibrom Postoperative inflammation in patients who have undergone cataract extraction U.S. $12.8 Nastech (NSTK)/QOL Medical Nascobal...
BioCentury | Sep 11, 2006
Clinical News

PreHistin cyanocobalamin: Completed Phase III enrollment

...treat moderate to moderately severe seasonal allergic rhinitis. Cobalis Corp. (CLSC), Irvine, Calif. Product: PreHistin cyanocobalamin...
BioCentury | Sep 11, 2006
Clinical News

PreHistin cyanocobalamin: Completed Phase III enrollment

...treat moderate to moderately severe seasonal allergic rhinitis. Cobalis Corp. (CLSC), Irvine, Calif. Product: PreHistin cyanocobalamin...
BioCentury | Jul 31, 2006
Clinical News

PreHistin cyanocobalamin: Phase III started

...an additional 3 weeks into the allergy season. Cobalis Corp. (CLSC), Irvine, Calif. Product: PreHistin cyanocobalamin...
Items per page:
1 - 10 of 40